A diabetes patient’s ambivalence about changing their diet or taking their insulin can stand between successful management of their disease and a further escalation that could lead to blindness, limb removal, or even death.
That’s where motivational interviewing makes a difference, says Maureen Hennessey, PhD, senior vice president and director of quality and population health solutions, and Elizabeth Oyekan, PharmD, senior director of quality and population health solutions, at New York-based Precision for Value. The company consults with pharmaceutical and life science clients in demonstrating the value and outcomes of their medical products.
Hennessey and Oyekan discussed how motivational interviewing can improve patient outcomes at the Academy of Managed Care Pharmacy Managed Care and Specialty Pharmacy Annual Meeting, which took place in Boston April 23 to 26.
Hennessey describes motivational interviewing as a patient-centric style of communication that helps to elicit and motivate change. Motivational interviewing strategies are more collaborative than coercive or combative and more supportive than directive, she adds.
If, for example, a patient with diabetes typically eats potatoes for dinner every night, that can interfere with their diabetes treatment plan. Rather than arguing with a patient and telling them they shouldn’t eat potatoes, motivational interviewing techniques can help determine their willingness to eat a smaller portion size or eat potatoes less often, says Hennessey.
She says there are four steps of motivational interviewing, which include:
Oyekan says compassion and empathy are key to the practice of motivational interviewing.
Exercising both is helpful when determining why a patient isn’t adhering to treatment recommendations, such as failing to take their medications, says Hennessey.
Asking a patient to tell you more about why they’re not taking their medications is helpful, says Hennessey.
She shared the example of a male patient with diabetes who didn’t take his medications. With this patient, his father had a negative outcome as a result of his diabetes medications. The patient then learned that there were new, more effective medications available.
Healthcare professionals first need to understand where the patient is coming from, and then they need to ask for permission to educate them about new treatments, says Hennessey, noting that asking for permission to provide that information is key. It also gives the patient a collaborative stance from which to get more engaged in their own treatment plan.
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More